Bulent Aydogan
Overview
Explore the profile of Bulent Aydogan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
742
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmed S, Naeem S, Khan A, Qureshi B, Hussain A, Aydogan B, et al.
Front Artif Intell
. 2024 Apr;
7:1329737.
PMID: 38646416
Background And Purpose: We proposed an artificial neural network model to predict radiobiological parameters for the head and neck squamous cell carcinoma patients treated with radiation therapy. The model uses...
2.
Maahs L, Patel P, Koshy M, Sweiss K, Chen Z, Xu Z, et al.
Eur J Haematol
. 2024 Apr;
113(1):110-116.
PMID: 38566462
Objectives: Based on a previous phase 1 study, total marrow irradiation (TMI) at 9Gy was added to a myeloablative FluBu4 conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT) for...
3.
Gertsenshteyn I, Epel B, Giurcanu M, Barth E, Lukens J, Hall K, et al.
Front Med (Lausanne)
. 2023 Dec;
10:1339872.
PMID: 38116039
[This corrects the article DOI: 10.3389/fmed.2023.1269689.].
4.
Srivastava A, Jha D, Keles E, Aydogan B, Abazeed M, Bagci U
Annu Int Conf IEEE Eng Med Biol Soc
. 2023 Dec;
2023:1-4.
PMID: 38082949
Accurate segmentation of organs-at-risks (OARs) is a precursor for optimizing radiation therapy planning. Existing deep learning-based multi-scale fusion architectures have demonstrated a tremendous capacity for 2D medical image segmentation. The...
5.
Gertsenshteyn I, Epel B, Giurcanu M, Barth E, Lukens J, Hall K, et al.
Front Med (Lausanne)
. 2023 Oct;
10:1269689.
PMID: 37904839
Background: Clinical attempts to find benefit from specifically targeting and boosting resistant hypoxic tumor subvolumes have been promising but inconclusive. While a first preclinical murine tumor type showed significant improved...
6.
Hui S, Storme G, Wong J, Aristei C, Al Malki M, Aydogan B
Front Oncol
. 2023 Aug;
13:1240530.
PMID: 37538119
No abstract available.
7.
Sivasubramanian M, Chu C, Hsia Y, Chen N, Cai M, Tew L, et al.
Nanomaterials (Basel)
. 2023 Jun;
13(11).
PMID: 37299694
Although radiotherapy is one of the most important curative treatments for cancer, its clinical application is associated with undesired therapeutic effects on normal or healthy tissues. The use of targeted...
8.
Kavak A, Surucu M, Ahn K, Pearson E, Aydogan B
Front Oncol
. 2022 Nov;
12:924961.
PMID: 36330489
We evaluated the impact of respiratory motion on the lung dose during linac-based intensity-modulated total marrow irradiation (IMTMI) using two different approaches: (1) measurement of doses within the lungs of...
9.
Ahn K, Rondelli D, Koshy M, Partouche J, Hasan Y, Liu H, et al.
Front Oncol
. 2022 Oct;
12:942685.
PMID: 36267964
Purpose: Total marrow irradiation (TMI) involves optimization of extremely large target volumes and requires extensive clinical experience and time for both treatment planning and delivery. Although volumetric modulated arc therapy...
10.
Tran M, Hasan Y, Wang A, Yenice K, Partouche J, Stock W, et al.
Blood Adv
. 2022 Jul;
7(3):285-292.
PMID: 35851593
Relapse after allogeneic stem cell transplantation (allo-SCT) remains the primary cause of treatment failure. A second SCT can result in long-term survival in a subset of patients, but the relapse...